Supernus Pharmaceuticals
SUPN
SUPN
228 hedge funds and large institutions have $1.64B invested in Supernus Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 68 increasing their positions, 101 reducing their positions, and 33 closing their positions.
Holders
228
Holders Change
-5
Holders Change %
-2.15%
% of All Funds
3.61%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
32
Increased
68
Reduced
101
Closed
33
Calls
$5.37M
Puts
$4M
Net Calls
+$1.37M
Net Calls Change
+$2.48M
Top Buyers
1 |
WP
1
Woodline Partners
San Francisco,
California
|
$15.7M |
2 |
2
BlackRock
New York
|
$287M |
3 |
3
Goldman Sachs
New York
|
$17.8M |
4 |
SCM
4
Soleus Capital Management
Greenwich,
Connecticut
|
$8.11M |
5 |
5
Balyasny Asset Management
Chicago,
Illinois
|
$4.77M |